A Closer Look at Valuation as New ALK Inhibitor Data Presentation Approaches
Nuvalent (NUVL) has scheduled a webcast to present pivotal data from its Phase 1/2 ALKOVE-1 study. The presentation…
Gauging Valuation After Recent Modest Gains in Autonomous Vehicle Tech
Aurora Innovation (AUR) shares have edged slightly higher recently, following a modest uptick of about 2% in the…